Plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer
Epidermal growth factor receptor (EGFR) mutation tests are in vitro diagnostic (IVD) tests used to help identify adults with non-small-cell lung cancer (NSCLC) suitable for treatment with EGFR ...
Cancer treatment has evolved from a generalised approach to a more precise one. Advances in precision medicine have transformed the way oncologists diagnose, stage, and treat cancer. At the core of ...
We offer targeted detection of a previously characterized mutation within the family. From a fresh EDTA blood sample, DNA is extracted directly and the target region is amplified and directly ...
Using AI, we identified publications that likely reported a testing or mutation rate, filtered publications for cancer type, and identified sentences that likely reported rates. Rates and covariates ...
Experts discuss the necessity of ESR1 mutation testing when considering treatment with elacestrant in patients with estrogen receptor–positive (ER+)/HER2-negative (HER2–) metastatic breast cancer and ...
An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...
Plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer
A literature search was carried out for this briefing in accordance with the interim process and methods statement. This briefing includes the most relevant or best available published evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results